#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paroxysmal nocturnal haemoglobinuria Endocrine ophthalmopathy Candida infection White matter lesion Arteriovenous malformation Breast angiosarcoma Krabbe's disease Germ cell cancer Biotinidase deficiency Chondrosarcoma Heart disease congenital Biliary neoplasm Oesophageal carcinoma Retinal artery occlusion Synovial sarcoma recurrent More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Basic Information Testicular leiomyosarcoma – Basic Information Chondrosarcoma Waldenstrom’s macroglobulinaemia – Diagnostics Ocular melanoma – Trials in Disease Mantle cell lymphoma stage IV – Basic Information Combined immunodeficiency – Trials in Disease Pituitary-dependent Cushing’s syndrome – Basic Information Ewing’s sarcoma Fabry’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gedatolisib Betibeglogene Autotemcel E2814 AZD0516 Fondaparinux Sodium Cebsulfase Alfa Cannabis Sativa Flower Peposertib Cimetidine Hydrochloride Aptamer-4Ft Idecabtagene Vicleucel PALAZESTRANT TIFCEMALIMAB Upadacitinib Sodium Ascorbate FG001 Ciclesonide Ly3541860 AGANIRSEN Phenobarbital More therapies…

    Learn about Your Condition

    Retinal artery occlusion Mast cell activation syndrome Amyloidosis Ovarian cancer metastatic Neonatal respiratory failure Post cardiac arrest syndrome Kidney transplant rejection Malignant glioma Extra-osseous Ewing's sarcoma Sickle cell disease Ulcerative keratitis Mucopolysaccharidosis I Polyneuropathy Tuberculosis Bile duct adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on RZ358 for Treating Congenital Hyperinsulinism in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Hyperinsulinaemic hypoglycaemia
    • Hyperinsulinism
    Investigated Drugs:
    • Anti-(Insulin Receptor) Human Monoclonal Antibody
    Bulgaria Denmark France Germany Greece Spain

  • Study on the Effects of Finerenone on Kidney Health in Patients with Type 2 Diabetes

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • L-Arginine Hydrochloride
    • Ascorbic Acid
    • Iohexol
    Germany

  • Study on the Effectiveness and Safety of SYNB1934 for Adults with Phenylketonuria (PKU)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Escherichia Coli, Strain Nissle 1917, Expressing High Affinity Phenylalanine Transporter, Modified Phenylalanine Ammonia Lyase (S92G, H133M, I167K, L432I, V470A) And L-Amino Acid Deaminase
    • Esomeprazole
    • Ondansetron
    Denmark

  • Study on Fecal Microbiota Capsules vs. Placebo for Treating Non-Alcoholic Steatohepatitis in Patients

    Not recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain

  • Study on Tacrolimus Dosing for Stable Adult Kidney Transplant Patients in the First Year After Transplantation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Tacrolimus
    Austria Czechia France Germany The Netherlands Spain

  • Study on Pravastatin’s Effect on Insulin Resistance in Kidney Transplant and Chronic Kidney Disease Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Insulin resistance
    Investigated Drugs:
    • Anhydrous Glucose Bp
    • Glucose Monohydrate Ph. Eur.
    • Insulin Human (Rdna)
    Denmark
Previous Page
1 … 53 54 55 56 57 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!